期刊文献+

洛伐他汀对脓毒症大鼠肺损伤的保护作用及对脂联素表达的影响 被引量:3

Protective effects of lovastatin on lung injury and adiponectin expression in septic rats
原文传递
导出
摘要 目的:观察洛伐他汀对脓毒症大鼠肺损伤的保护作用及对脂联素表达的影响。方法健康雄性清洁级Wistar大鼠54只,体质量250~300 g,采用数字表法随机分为三组:假手术组(Sham组)、脓毒症组(CLP组)、洛伐他汀处理组(LOV组)。 Sham组及LOV组术前1周腹腔注射洛伐他汀4 mg/kg,CLP组则注射等体积的溶剂0.5%缩甲基纤维素钠(CMC)。各组术后4 h、12 h和24 h取支气管肺泡灌洗液(BALF)测定TNF-α及IL-6水平;取肺组织观察组织病理学改变及检测髓过氧化物酶(MPO)及丙二醛当量(MDA)含量;另取血标本检测血清脂联素水平。结果 Sham组4 h、12 h和24 h TNF-α含量分别是(1.80±0.13)pg/mL、(2.04±0.15)pg/mL和(1.93±0.19)pg/mL;IL-6含量分别是(20.56±0.23)pg/mL、(18.35±0.15)pg/mL和(21.23±0.20)pg/mL;MPO含量分别是(2.82±0.14)U/g组织、(2.88±0.07)U/g组织和(2.76±0.18)U/g组织;MDA含量分别是(3.32±0.12)nmol/mg、(3.09±0.11)nmol/mg和(3.21±0.08)nmol/mg;脂联素浓度分别是(2.68±0.14)μg/mL、(2.80±0.07)μg/mL和(2.86±0.18)μg/mL。与Sham组相比:(1)CLP组及LOV组肺损伤形态学改变明显,CLP组BALF中TNF-α含量[4 h、12 h和24 h分别是(4.23±0.18) pg/mL、(5.62±0.24)pg/mL和(5.14±0.10)pg/mL,t=28.41、30.98、36.62]及IL-6含量[4 h、12 h和24 h分别是(39.12±0.17)pg/mL、(47.25±0.21)pg/mL和(44.69±0.27)pg/mL,t=158.90、273.40、127.28]增高,肺组织匀浆中MPO水平[4 h、12 h和24 h分别是(4.85±0.13) U/g组织、(6.17±0.08) U/g组织和(7.84±0.10)U/g组织,t=26.39、79.40、60.43]及MDA水平[4 h、12 h和24 h分别是(6.24±0.06)nmol/mg、(7.56±0.15)nmol/mg和(8.43±0.10)nmol/mg,t=53.31、58.86、90.06]增高、血清中脂联素水平[4 h、12 h和24 h分别是(1.35±0.10)μg/mL、(1.17±0.07)μg/mL和(1.24±0.11)μg/mL,t=19.86、12.75、18.81]降低(均P<0.05);(2)LOV组BALF中TNF-α含量[4 h、12 h和24 h分别是(2.85±0.17)pg/mL、(3.72±0.13)pg/mL和(3.24±0.09)pg/mL,t=12.02、20.73、16.68]及IL-6含量[4 h、12 h和24 h分别是(30.75±0.22)pg/mL、(37.52±0.29)pg/mL和(32.43±0.26)pg/mL,t=78.42、68.29、83.67]增高,肺组织匀浆中MPO水平[4 h、12 h和24 h分别是(3.59±0.05) U/g组织、(4.67±0.11) U/g组织和(5.33±0.05) U/g组织,t=12.03、33.63、33.70]及MDA水平[4 h、12 h和24 h分别是(4.45±0.10)nmol/mg、(5.01±0.11)nmol/mg和(5.83±0.04)nmol/mg,t=17.72、30.23、71.75]亦增高、血清中脂联素水平[4 h、12 h和24 h分别是(2.09±0.08)μg/mL、(2.07±0.05)μg/mL和(2.03±0.10)μg/mL,t=8.96、20.79、6.30]亦降低(均P<0.05)。而LOV处理组与CLP组比较,肺损伤形态学改变减轻,TNF-α(t=13.46、17.05、15.43)、IL-6(t=73.70、64.10、80.12)含量均有下降,MPO(t=22.16、27.01、32.86)及MDA(t=37.59、42.72、59.13)水平均降低,同时血清脂联素水平(t=14.15、8.10、3.19)均显著提高(均P<0.05)。结论洛伐他汀可降低脓毒症大鼠TNF-α、IL-6等的浓度,减轻炎性反应及氧化应激损伤,减轻脓毒症肺损伤,并能提升脓毒症大鼠血清中脂联素水平。 Objective To observe the protective effects of lovastatin against lung injury and the expression changes of adiponectin in the septic rats.Methods Fifty four male Wistar rats weighting 250-300g were randomly divided into the three groups:sham operation group (group Sham) ,sepsis group (group CLP) and lovastatin interven tion group (group LOV).Rats were injected with lovastatin (4mg/kg) or 0.5%CMC (vehicle) for five days and then subjected to CLP.At 4h,12h and 24h after operation.BALF was collected to determine the levels of TNF-αand IL-6,lung tissue was obtained to observe histopathological changes,and to detect the content of MPO and MDA,the blood sample was obtained to detect the level of adiponectin.Results In the group Sham,at 4h,12h and 24h time points,the levels of TNF-αwere (1.80 ±0.13)pg/mL,(2.04 ±0.15)pg/mL and (1.930.19)pg/mL;the levels of IL-6 were (20.56 ±0.23)pg/mL,(18.35 ±0.15) pg/mL and (21.23 ±0.20) pg/mL;the contents of MPO were (2.82 ±0.14) U/g tissue,(2.88 ±0.07) U/g tissue and (2.76 ±0.18) U/g tissue;and the levels of MDA were (3.32 ±0.12)nmol/mg,(3.09 ±0.11)nmol/mg and (3.21 ±0.08)nmol/mg;the concentrations of adiponectin were (2.68 ±0.14)μg/mL,(2.80 ±0.07)μg/mL and (2.86 ±0.18)μg/mL.Compared with group Sham,both LOV group and CLP group had increased pulmonary damage:(1)the levels of TNF-α[4h,12h and 24h were (4.23 ± 0.18)pg/mL,(5.62 ±0.24)pg/mL and (5.14 ±0.10)pg/mL,t=28.41,30.98 and 36.62]and IL-6[4h,12h and 24h were (39.12 ±0.17) pg/mL,(47.25 ±0.21) pg/mL and (44.690.27) pg/mL,t =158.90,273.40 and 127.28] of the CLP group in BALF were both increased,and MPO[4h,12h and 24h were (4.85 ±0.13) U/g tissue, (6.17 ±0.08)U/g tissue and (7.84 ±0.10)U/g tissue,t=26.39,79.40 and 60.43]and MDA[4h,12h and 24h were (6.24 ±0.06)nmol/mg,(7.56 ±0.15)nmol/mg and (8.43 ±0.10)nmol/mg,t=53.31,58.86 and 90.06] concentrations in lung homogenate were raised with the decreased expression of serum adiponectin[4h,12h and 24h were (1.35 ±0.10)μg/mL,(1.17 ±0.07)μg/mL and (1.24 ±0.11)μg/mL,t=19.86,12.75 and 18.81](all P〈0.05);(2) meanwhile the levels of TNF-α[4h,12h and 24h were (2.85 ±0.17) pg/mL,(3.720.13) pg/mL and (3.240.09)pg/mL,t=12.02、20.73 and 16.68]and IL-6[4h,12h and 24h were (30.75 ±0.22)pg/mL, (37.52 ±0.29)pg/mL and (32.43 ±0.26)pg/mL,t=78.42,68.29 and 83.67]in BALF of the LOV group were all increased,the contents of MPO[4h,12h and 24h were(3.59 ±0.05)U/g tissue,(4.67 ±0.11)U/g tissue and (5.33 ± 0.05)U/g tissue,t=12.03,33.63 and 33.70]and MDA[4h,12h and 24h were (4.45 ±0.10)nmol/mg,(5.01 ± 0.11)nmol/mg and (5.83 ±0.04) nmol/mg,t =17.72,30.23 and 71.75] were also increased with the serum adiponectin concentrations[4h,12h and 24h were (2.09 ±0.08)μg/mL,(2.07 ±0.05)μg/mL and (2.03 ± 0.10)μg/mL,t=8.96,20.79 and 6.30]dicreased(all P〈0.05).There were less histopathological changes in the LOV group,and the levels of TNF-α(t=13.46,17.05 and 15.43),IL-6(t=73.70,64.10 and 80.12),MPO(t=22.16,27.01and 32.86) and MDA(t=37.59,42.72 and 59.13) were lower than those in CLP group,also the level of adiponectin(t=14.15,8.10 and 3.19) increased siginificantly(all P〈0.05).Conclusion Administration of lovastatin could attenuate lung injury of the sepsis by down-regulate the level of TNF-αand IL-6,with reduced inflam-matory response and oxidative stress,and could upregulate the level of adiponectin in serums of rats with sepsis.
出处 《中国基层医药》 CAS 2014年第23期3521-3524,共4页 Chinese Journal of Primary Medicine and Pharmacy
基金 江苏省南京市医学科技发展项目(201108028,ZKX11028)
关键词 洛伐他汀 脓毒症 肺损伤 脂联素 Lovastatin Sepsis Lung injury Adiponectin
  • 相关文献

参考文献16

  • 1Mikkelsen ME,Shah CV1Meyer NJ,et al.The epidemiology of a-cute respiratory distress syndrome in patients presenting to the e-mergency department with severe sepsis[J].Shock,2013,40(5):375-381.
  • 2Zeichner S,Mihos CG,Santana 0.The pleiotropic effects and therapeutic potential of the hydroxy-methyl-glutaryl-CoA reductase inhibitors in malignancies:a comprehensive review[J].J Cancer Res Ther,2012,8(2):176-183.
  • 3郑其亮,钟江华,张光星.洛伐他汀对急性心肌梗死患者血清脂联素浓度的影响[J].中国现代医学杂志,2010,20(16):2523-2525. 被引量:4
  • 4Planagumai A,Pfeffer MA,Rubin G,et al.Lovastatin decreases a-cute mucosal inflammation via 15-epi-lipoxin A4[J].Mucosal Immunol,2010,3(3):270-279.
  • 5Rittirsch D,Huber-Lang MS,Flierl MA,et al.Immunodesign of experimental sepsis by cecal ligation and puncture[J].Nat Pro-toc,2009,4(1):31-36.
  • 6Adib-Conquy M,Cavaillon JM.Host inflammatory and anti-inflammatory response during sepsis[J].Pathol Biol,2012,60(5):606-613.
  • 7Seeley EJ.Updates in the management of acute lung jnjury:a focus on the overlap between AKI and ARDS[J].Adv Chronic Kidney Dis,2013,20(1):14-20.
  • 8Li J,Li D,Liu X,et al.Human umbilical cord mmesenchymal stem cells reduce systemic inflammation and attenuate LPS-induced a-cute lung injury[J].J Inflamm,2012,9(1):33.
  • 9Almuti K,Rimawi R,Spevack D,et al.Effects of statins beyond lipid lowering:potential for clinical benefits[J].Int Cardiol,2006,109(1):7-15.
  • 10Massy ZA,Kim Y,Guijarro C,et al.Low-density lipoprotein-in-duced expression of inlerleukin-6,a markei.of human mesangial cell inflammation:effects of oxidation and modulation by lovastatin[J].Biochem Biophys Res Commun,2000,267(2):536-540.

二级参考文献20

  • 1霍丽梅,宋光耀,叶蔚.脂联素与动脉粥样硬化[J].心血管病学进展,2005,26(3):299-302. 被引量:15
  • 2葛庆峰,闫杰.急性心肌梗死患者血清脂联素水平的动态变化[J].临床荟萃,2005,20(11):601-603. 被引量:13
  • 3SERRUYS PW, DE FEYTER P, MACAYA C, et al. Fluvastafin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial [J]. JAMA, 2002, 287(24): 3215-3222.
  • 4ROSS R. Atherosclerosis is an inflammation disease[J]. Am Heart J, 1999, 158: 419--420.
  • 5OUCHI N, KIHARA S, FUNAHASHI T, et al. Obestity, adiponectin and vascular inflammatory disease [J]. Lipidology, 2003, 14(6): 561-566.
  • 6OUCHI N, KIHARA S, ARITA Y, et al. Adiponectin, an adipocyte-derlved plasma protein, inhibits endothelial NF-kappaB signaling through a c-AMP-dependent pathway [J]. Circulation, 2000, 102(11): 1296-1301.
  • 7The Scandinavian Simvastatin Survival Study Group. Randomize1 tried of cholesterol lowering in 4444 patients with coronary heart diseases: the scandinavian sinvastatin survival study (4s) [J]. Lancet, 199,1, 344: 1383.
  • 8GURNDY SM, CLEEMAN JI, MERZ CN, et al. Implications of recent clinical trails for the national cholesterol education program adult treatment panel Ⅲ guidelines[J]. Circulation, 2004, 110: 227-239.
  • 9Martin GS,Mannino DM,Eaton S,et al.The epidemiology of sepsis in the United States from 1979 through 2000.N Engl J Med,2003,348(16):1546-1554.
  • 10Lara-Castro C,Fu Y,Chung BH,et al.Adiponectin and the metabolic syndrome:mechanisms mediating risk for metabolic and cardiovascular disease.Curr Opin Lipidol,2007,18(3):263-270.

共引文献16

同被引文献60

  • 1Becker BF, Chappell D, Bruegger D, et al. Therapeutic strat- egies targeting the endothelial glycocalyx: acute deficits, but great potential [ J ]. Cardiovasc Res, 2010,87 ( 2 ) : 300-310.
  • 2Hayashida A, Bartlett AH, Foster TJ, et al. Staphylococcus aureus beta-toxin induces lung injury through syndecan-1 [ J ]. Am J Pathol,2009,174(2) :509-518.
  • 3Chen SF, Hung TH, Chen CC, et al. Lovastatin improves his- tological and functional outcomes and reduces inflammation after experimental traumatic brain injury[ J]. Life Sci, 2007,81 ( 4 ) : 288-298.
  • 4Park YS, Guijarro C, Kim Y, et al. Lovastatin reduces glo- merular macrophage influx and expression of monocyte chemoat- tractant protein-1 mRNA in nephrotic rats[ J]. Am J Kidney Dis, 1998,31 (1) : 190-194.
  • 5Curry FE, Adamson RH. Endothelial glycocalyx: permeability barrier and mechanosensor[ J]. Ann Biomed Eng,2012,40(4) : 828-839.
  • 6Schmidt EP, Yang Y, Janssen WJ, et al. The pulmonary endothe- lial glycocalyx regulates neutrophil adhesion and lung injury during experimental sepsis[J]. Nat Med,2012,18(8):1217-1223.
  • 7Teng YH, Aquino RS, Park PW. Molecular functions of synde- can-1 in disease[ J]. Matrix Biol,2012,31 ( 1 ) :3-16.
  • 8Steppan J, Hofer S, Funke B, et aL Sepsis and major abdominal surgery lead to flaking of the endothelial glycocalix [J]. J Surg Res,2011,165(1):136-141.
  • 9Nelson A, Berkestedt I, Schmidtchen A, et al. Increased levels of glyeosaminoglycans during septic shock : relation to mor- tality and the antibacterial actions of plasma[ J~. Shock,2008,30 (6) :623-627.
  • 10Kjeldson L,Johnsen AH,Sengelov H,et al. Isolation and primary structure of NGAL,a novel protein associated with human neutro- phil gelatinase [J]. J Biol Chem, 1993,268 (14) : 10425-10432.

引证文献3

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部